Literature DB >> 16407883

Transmembrane pressure modulation in high-volume mixed hemodiafiltration to optimize efficiency and minimize protein loss.

L A Pedrini1, G Cozzi, P Faranna, A Mercieri, P Ruggiero, S Zerbi, A Feliciani, A Riva.   

Abstract

The aim of the present study was transmembrane pressure (TMP) modulation in high-volume mixed hemodiafiltration (HDF) to optimize efficiency and minimize protein loss. The optimal flow/pressure conditions in on-line mixed HDF assisted with a feedback control of TMP were defined in this prospective randomized study in order to obtain maximal efficiency in solute removal while minimizing potential side effects. Two different TMP profiles in mixed HDF were compared in 12 unselected patients who underwent two study periods of 2 weeks each in cross-over randomized sequence: (A) constant TMP at around 300 mmHg and (B) profiled TMP, in which TMP was slowly increased from a low initial value to the maximal value. In both procedures, the mean volume exchange was 10.6+/-1.4 l/h. Mean filtration fraction was 53%. Instantaneous beta2-microglobulin (beta2-m) clearance was higher at the start of the session with profiled TMP (207+/-35 vs 194+/-28 ml/min, P<0.005), whereas no differences were found at the end (135+/-19 vs 132+/-19 ml/min). Profiled TMP resulted in a higher mean beta2-m clearance of the session (97.0+/-15.4 vs 87.8+/-18.3 ml/min, P<0.01), in lower albumin loss in the first 30 min (0.62+/-0.14 vs 0.98+/-0.18 g, P<0.0001), and, in the whole session (3.98+/-1.19 vs 5.24+/-0.77 g, P<0.001), in higher dialyzer ultrafiltration coefficients and lower resistance indexes. This study showed that the TMP feedback modulation in mixed HDF was highly effective in maintaining very high ultrafiltration rates and filtration fractions, and minimized potential side effects as a result of the improved preservation of membrane permeability and more favorable dialyzer pressure regimen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407883     DOI: 10.1038/sj.ki.5000110

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study "Hephaestus".

Authors:  Francesco Pizzarelli; Vincenzo Cantaluppi; Vincenzo Panichi; Alessandro Toccafondi; Giuseppe Ferro; Serena Farruggio; Elena Grossini; Pietro Claudio Dattolo; Vincenzo Miniello; Massimiliano Migliori; Cristina Grimaldi; Aldo Casani; Maurizio Borzumati; Stefano Cusinato; Alessandro Capitanini; Alessandro Quercia; Oliviero Filiberti; Lucia Dani
Journal:  J Nephrol       Date:  2021-02-09       Impact factor: 3.902

Review 2.  Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine.

Authors:  Bernard Canaud; Stefano Stuard; Frank Laukhuf; Grace Yan; Maria Ines Gomez Canabal; Paik Seong Lim; Michael A Kraus
Journal:  Clin Kidney J       Date:  2021-12-27

Review 3.  Mass Transport in High-Flux Hemodialysis: Application of Engineering Principles to Clinical Prescription.

Authors:  Farzad Mohajerani; William R Clark; Claudio Ronco; Vivek Narsimhan
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-11       Impact factor: 10.614

Review 4.  Treatment with echinocandins during continuous renal replacement therapy.

Authors:  Francisco González de Molina; Maria de Los Ángeles Martínez-Alberici; Ricard Ferrer
Journal:  Crit Care       Date:  2014-03-28       Impact factor: 9.097

5.  Association Between Hemodiafiltration and Hypoalbuminemia in Middle-Age Hemodialysis Patients.

Authors:  Cheng-Hao Weng; Ching-Wei Hsu; Ching-Chih Hu; Tzung-Hai Yen; Wen-Hung Huang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients.

Authors:  Luciano A Pedrini; Adam M Zawada; Anke C Winter; Jenny Pham; Gudrun Klein; Melanie Wolf; Astrid Feuersenger; Pio Ruggiero; Annalisa Feliciani; Carlo Barbieri; Adelheid Gauly; Bernard Canaud; Stefano Stuard
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

7.  Clinical outcomes of hemodialysis patients in a public-private partnership care framework in Italy: a retrospective cohort study.

Authors:  L A Pedrini; A C Winter; F Cerino; A M Zawada; M Garbelli; A Feuersenger; A Feliciani; P Ruggiero; S Civardi; C Amato; B Canaud; S Stuard; A Karch; A Gauly
Journal:  BMC Nephrol       Date:  2019-02-01       Impact factor: 2.388

Review 8.  The Influence of Inflammation on Anemia in CKD Patients.

Authors:  Anna Gluba-Brzózka; Beata Franczyk; Robert Olszewski; Jacek Rysz
Journal:  Int J Mol Sci       Date:  2020-01-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.